Predictions
Atlanticus Holdings Corp
Start price
Target price
Perf. (%)
€32.40
04.09.22
04.09.22
€11.00
04.09.23
04.09.23
-
17.09.22
17.09.22
Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
ShiftPixy Inc.
Start price
Target price
Perf. (%)
€31.30
10.09.22
10.09.22
€11.00
10.09.23
10.09.23
-37.16%
17.09.22
17.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€7.24
06.09.22
06.09.22
-
06.09.23
06.09.23
10.02%
17.09.22
17.09.22
Capable Management
Good culture
Could be worthwhile Investment >10% per year
Little innovation
Amyris Biotechnology Inc.
Start price
Target price
Perf. (%)
€5.00
23.12.21
23.12.21
-
23.12.22
23.12.22
-22.05%
13.09.22
13.09.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
Assembly Biosciences Inc.
Start price
Target price
Perf. (%)
€2.76
12.09.21
12.09.21
€3.00
12.09.22
12.09.22
-24.82%
13.09.22
13.09.22
Could be worthwhile Investment >10% per year
Seres Therapeutics Inc
Start price
Target price
Perf. (%)
€4.99
12.09.21
12.09.21
€8.00
12.09.22
12.09.22
36.81%
13.09.22
13.09.22
Could be worthwhile Investment >10% per year
Pro-Dex Inc.
Start price
Target price
Perf. (%)
€20.00
12.09.21
12.09.21
€23.00
12.09.22
12.09.22
-1.50%
13.09.22
13.09.22
Could be worthwhile Investment >10% per year
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€7.98
08.09.22
08.09.22
€9.00
08.09.23
08.09.23
11.61%
09.09.22
09.09.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€26.71
17.08.22
17.08.22
€5.00
17.08.23
17.08.23
-69.11%
09.09.22
09.09.22
Risky Investment
High risks for its business
ShiftPixy Inc.
Start price
Target price
Perf. (%)
€13.48
05.09.22
05.09.22
-
05.09.23
05.09.23
113.53%
09.09.22
09.09.22
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Probably not worthwhile Investment
Lower EBIT Margin than peer group
RCI Hospitality Holdings Inc
Start price
Target price
Perf. (%)
€55.00
07.09.21
07.09.21
-
07.09.22
07.09.22
20.91%
08.09.22
08.09.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good rating
EBIT growth >5% per year expected
Codexis Inc.
Start price
Target price
Perf. (%)
€34.80
05.11.21
05.11.21
€50.00
31.12.23
31.12.23
-79.99%
07.09.22
07.09.22
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€202.35
31.08.21
31.08.21
€350.00
31.12.23
31.12.23
-85.81%
07.09.22
07.09.22
Could be worthwhile Investment >10% per year
Novavax Inc.
Start price
Target price
Perf. (%)
€212.55
05.09.21
05.09.21
€333.00
05.09.22
05.09.22
-85.70%
06.09.22
06.09.22
Top 10 in its market
Could be worthwhile Investment >10% per year
Leading role in innovation
Very Future proof/growth oriented business model
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€9.88
22.08.22
22.08.22
€14.00
22.08.23
22.08.23
-17.77%
03.09.22
03.09.22
Capable Management
Good culture
Could be worthwhile Investment >10% per year
Little innovation
Ziopharm Oncology
Start price
Target price
Perf. (%)
€1.99
07.09.21
07.09.21
€4.00
31.12.23
31.12.23
52.84%
01.09.22
01.09.22
Could be worthwhile Investment >10% per year
Plug Power Inc.
Start price
Target price
Perf. (%)
€28.35
27.08.22
27.08.22
€28.00
27.08.23
27.08.23
2.82%
30.08.22
30.08.22
Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Novavax Inc.
Start price
Target price
Perf. (%)
€51.80
27.05.22
27.05.22
€68.00
27.05.23
27.05.23
-32.47%
27.08.22
27.08.22
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€9.57
09.08.22
09.08.22
€7.00
09.08.23
09.08.23
11.81%
27.08.22
27.08.22
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Very low/no dividend yield expected
very negative Cash Flow expected
Tempest Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.22
23.08.21
23.08.21
-
23.08.22
23.08.22
-78.40%
24.08.22
24.08.22
Risky Investment
Bed Bath & Beyond Inc.
Start price
Target price
Perf. (%)
€10.10
22.08.22
22.08.22
€10.00
22.08.23
22.08.23
-13.85%
23.08.22
23.08.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Agile Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.25
05.07.22
05.07.22
€5.00
05.07.23
05.07.23
-25.76%
23.08.22
23.08.22